The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Society of Family Planning clinical recommendations: cervical preparation for dilation and evacuation at 20–24 weeks' gestation
Open accessAbstract
Although only 1.3% of abortions in the United States are between 20 and 24 weeks' gestation, these procedures are associated with elevated risks of morbidity and mortality. Adequate cervical preparation before dilation and evacuation (D&E) at 20-24 weeks' gestation reduces procedural risk. For this gestational range, at least one day of cervical preparation with osmotic dilators is recommended before D&E. The use of overnight osmotic dilators alone is sufficient for most D&Es at 20-24 weeks' gestation. Dilapan-S® dilators require a shorter time to achieve maximum dilation, may be more effective than laminaria and may increase the likelihood of success on the first D&E attempt. The use of adjunctive mifepristone administered one-day pre-operatively at the time of osmotic dilator placement, should be considered because evidence demonstrates that it makes D&E subjectively easier at 20-24 weeks without increasing side effects. While older studies suggest that two-days of serial osmotic dilators provide greater dilation than one day of dilators, adjunctive mifepristone may be comparable to a second day of dilators. Adjunctive misoprostol administered on the day of D&E does not appear to affect initial cervical dilation and procedure time and compared with mifepristone is associated with more side effects, such as pain and nausea. Using overnight mifepristone and same-day misoprostol without osmotic dilators at 20-24 weeks' gestation lengthens D&E procedure time and appears to increase immediate complications, at least among less experienced providers. Some evidence shows the feasibility of same-day cervical preparation before D&E at 20-24 weeks using Dilapan-S® with adjunctive misoprostol or serial repeat dosing of misoprostol, but same-day preparation should be limited to providers with significant experience with these regimens. The Society of Family Planning recommends preoperative cervical preparation before D&E at 20-24 weeks' gestation. Further studies are needed to clarify the best means of preparing the cervix in order to minimize abortion complications and improve outcomes in this gestational range.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Other data confirm that STSA training and services are not available in all hospitals, limiting patients' reproductive options.18”
From First and Second-Trimester Surgical Abortion Providers and Services in 2019: Results From the Canadian Abortion Provider Survey (2023) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Boeckel, T. P. V., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70780-7 · Cited by 2,355
Pregnancy-Related Mortality in the United States, 2006–2010
Creanga, A. A., Berg, C. J., Syverson, C. J., Seed, K., Bruce, F. C., & Callaghan, W. M. (2014) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000564 · Cited by 1,064
Goldberg, A. B., Greenberg, M. B., & Darney, P. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440107 · Cited by 458
RU486 (MIFEPRISTONE): Mechanisms of Action and Clinical Uses
Cadepond, F., Ulmann, A., & Baulieu, E. E. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.129 · Cited by 424
The Comparative Safety of Legal Induced Abortion and Childbirth in the United States
Raymond, E. G., & Grimes, D. A. (2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31823fe923 · Cited by 406
Prevention of Uterine Perforation During Curettage Abortion
Grimes, D. A. (1984) · JAMA · doi:10.1001/jama.1984.03340400036021 · Cited by 208
MEASURES TO PREVENT CERVICAL INJURY DURING SUCTION CURETTAGE ABORTION
Schulz, K. F., Grimes, D., & Cates, W. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92464-9 · Cited by 193
RETIRED: Labor induction abortion in the second trimester
Borgatta, L., & Kapp, N. (2011) · Contraception · doi:10.1016/j.contraception.2011.02.005 · Cited by 181
Complications after Second Trimester Surgical and Medical Abortion
Grossman, D., Blanchard, K., & Blumenthal, P. D. (2008) · Reproductive Health Matters · doi:10.1016/s0968-8080(08)31379-2 · Cited by 157
Second-trimester abortion by dilatation and evacuation: an analysis of 11,747 cases.
Wf, P., Fn, B., Mr, G., et al. (1983) · PubMed · Cited by 152
Flagged first, then by citations
Cited by
Sorted by citations
Renner, R., Ennis, M., Kean, L., Brooks, M., Dineley, B., Pymar, H., Norman, W. V., & Guilbert, E. (2023) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2023.08.001 · Cited by 4
Metadata
- Authors
- Diedrich, J. T., Drey, E. A., & Newmann, S. J.
- Affiliations
- University of California, Irvine (US)
- University of California, San Francisco (US)
- Corresponding author
- Diedrich, Justin T.
- Venue
- Contraception
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 101
- Issue
- 5
- Pages
- 286-292
- ISSN
- 0010-7824 (ISSN-L)
- OpenAlex
- W3003406628
- Cited by
- 39
- References
- 49
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 8 · 2023: 6 · 2022: 4 · 2021: 7 · 2020: 2
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Contraception (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Health Sciences › Medicine › Obstetrics and Gynecology › Maternal and Perinatal Health Interventions
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and fetal healthcare
- Keywords
- cervical preparation, dilation and evacuation, second-trimester abortion, osmotic dilators, Dilapan-S, mifepristone, misoprostol, Laminaria, cervical dilatation, procedural complications
- MeSH terms
- Abortifacient Agents, Abortion, Induced, Cervix Uteri, Extraction, Obstetrical, Family Planning Services, Female, Humans, Labor Stage, First, Laminaria, Pregnancy, Pregnancy Trimester, Second, Preoperative Care, Societies, Medical, Mifepristone, Misoprostol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review